Pilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed Glioblastoma
Clinical trial NCT04119674 · COMPLETED
Trial details
- NCT number
- NCT04119674
- Sponsor
- Zhejiang Cancer Hospital
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-19
- Primary completion
- 2022-08-23
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.